Shaanxi Kanghui Pharm Co Ltd
Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular, tranquilizer, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, lin… Read more
Shaanxi Kanghui Pharm Co Ltd (603139) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.010x
Based on the latest financial reports, Shaanxi Kanghui Pharm Co Ltd (603139) has a cash flow conversion efficiency ratio of 0.010x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥7.14 Million) by net assets (CN¥745.41 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shaanxi Kanghui Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Shaanxi Kanghui Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shaanxi Kanghui Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shaanxi Kanghui Pharm Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
STECON GROUP NON-VOTING DR PCL
BK:STECON
|
N/A |
|
Qtone Education Group Guangdong Ltd
SHE:300359
|
-0.005x |
|
Parke Bancorp Inc
NASDAQ:PKBK
|
0.035x |
|
Henan Rebecca Hair Products Co Ltd
SHG:600439
|
0.031x |
|
Community Health Systems Inc
NYSE:CYH
|
-0.073x |
|
Eventbrite Inc
F:EB4
|
0.194x |
|
Creotech Instruments S.A.
WAR:CRI
|
-0.206x |
|
Jiangsu Phoenix Property Investment Co Ltd
SHG:600716
|
0.009x |
Annual Cash Flow Conversion Efficiency for Shaanxi Kanghui Pharm Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Shaanxi Kanghui Pharm Co Ltd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥906.90 Million | CN¥37.29 Million | 0.041x | +158.14% |
| 2023-12-31 | CN¥1.02 Billion | CN¥-72.13 Million | -0.071x | -243.87% |
| 2022-12-31 | CN¥1.03 Billion | CN¥50.43 Million | 0.049x | +638.84% |
| 2021-12-31 | CN¥1.12 Billion | CN¥7.42 Million | 0.007x | -92.38% |
| 2020-12-31 | CN¥1.07 Billion | CN¥93.72 Million | 0.087x | -17.40% |
| 2019-12-31 | CN¥1.02 Billion | CN¥107.53 Million | 0.106x | +65.34% |
| 2018-12-31 | CN¥979.31 Million | CN¥62.64 Million | 0.064x | +33.81% |
| 2017-12-31 | CN¥912.11 Million | CN¥43.60 Million | 0.048x | -65.16% |
| 2016-12-31 | CN¥522.81 Million | CN¥71.72 Million | 0.137x | +120.22% |
| 2015-12-31 | CN¥457.58 Million | CN¥28.50 Million | 0.062x | +8.38% |
| 2014-12-31 | CN¥395.37 Million | CN¥22.72 Million | 0.057x | -51.42% |
| 2013-12-31 | CN¥332.63 Million | CN¥39.35 Million | 0.118x | +54.43% |
| 2012-12-31 | CN¥210.43 Million | CN¥16.12 Million | 0.077x | -- |